1-150966161-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_022075.5(CERS2):c.1130G>C(p.Arg377Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000689 in 1,610,470 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_022075.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CERS2 | NM_022075.5 | c.1130G>C | p.Arg377Pro | missense_variant | Exon 11 of 11 | ENST00000368954.10 | NP_071358.1 | |
CERS2 | NM_181746.4 | c.1130G>C | p.Arg377Pro | missense_variant | Exon 11 of 11 | NP_859530.1 | ||
CERS2 | XM_011509451.3 | c.1190G>C | p.Arg397Pro | missense_variant | Exon 11 of 11 | XP_011507753.1 | ||
CERS2 | XM_011509452.4 | c.1130G>C | p.Arg377Pro | missense_variant | Exon 11 of 11 | XP_011507754.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152120Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000485 AC: 12AN: 247472Hom.: 0 AF XY: 0.0000448 AC XY: 6AN XY: 133984
GnomAD4 exome AF: 0.0000686 AC: 100AN: 1458350Hom.: 0 Cov.: 35 AF XY: 0.0000593 AC XY: 43AN XY: 725648
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152120Hom.: 0 Cov.: 31 AF XY: 0.0000673 AC XY: 5AN XY: 74292
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1130G>C (p.R377P) alteration is located in exon 11 (coding exon 10) of the CERS2 gene. This alteration results from a G to C substitution at nucleotide position 1130, causing the arginine (R) at amino acid position 377 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at